Besifloxacin Hydrochlorid

Besifloxacin Hydrochlorid
Product Description

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan. The eye drop was approved by the United States Food and Drug Administration (FDA) on May 29, 2009, and marketed under the trade name Besivance. We are leading manufacturer of Besifloxacin and its intermediates. Please contact us for more information.

Flax Laboratories

  • IN
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer
Specifications

Flax Laboratories

  • IN
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer

More Products from Flax Laboratories (2)

  • Alcaftadine

    Product Alcaftadine

    Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist. It was approved by the U.S. Food and Drug Administration in 2010 under the trade name Lastacaft. We are manufacturing Alcaftadine API and other ophthalmic API's. Please contact us ...
  • Amorolfine Hydrochloride BP

    Product Amorolfine Hydrochloride BP

    Amorolfine (or amorolfin), is a morpholine antifungal drug that inhibits ?14-sterol reductase and cholestenol ?-isomerase, which depletes ergosterol and causes ignosterol to accumulate in the fungal cytoplasmic cell membranes. Marketed as Curanail, Loceryl, Locetar, and Odenil, amorolfine is commonly avail...

Flax Laboratories resources (1)